Form 4: NHC Sr. VP Operations Granted 14,000 Stock Options

Timothy J. Shelly, Senior Vice President of Operations at National Healthcare Corp, received a grant of 14,000 stock options with a vesting schedule over three years.

Summary

• Timothy J. Shelly, Sr.VP Operations at National Healthcare Corp (NHC), was granted 14,000 stock options.
• The options were granted on February 23, 2026, under the 2020 Omnibus Equity Incentive Plan.
• The exercise price for these new options is $157.13 per share.
• These options will vest ratably over three years, with one-third vesting on February 23, 2027, another third on February 23, 2028, and the final third on February 23, 2029.
• The options have an expiration date of February 24, 2031.
• This transaction is exempt from Section 16(b) pursuant to Rule 16b-3(d).
• Following this grant, Mr. Shelly beneficially owns a total of 35,400 derivative securities (options).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting standard executive incentive practices and a commitment to aligning management's long-term interests with shareholder value, without indicating any immediate operational or financial changes.

Positives

• The grant of 14,000 stock options aligns the executive's interests with long-term shareholder value through a multi-year vesting schedule.
• The options were granted under an existing equity incentive plan (2020 Omnibus Equity Incentive Plan), indicating a structured approach to executive compensation.

Future Outlook

The newly granted stock options for Timothy J. Shelly are structured with a three-year vesting schedule, indicating a long-term incentive for the executive, with full vesting expected by February 23, 2029.

Industry Context

StockSavvy.ai notes that the grant of stock options to a Senior Vice President of Operations is a standard practice in executive compensation across the healthcare industry, aiming to incentivize long-term performance and align management interests with shareholder returns. This type of equity award is common for retaining key talent and motivating strategic execution.

Comparison to Industry Standards

• The use of stock options with a multi-year vesting schedule is a common compensation tool, comparable to practices at peer healthcare companies such as HCA Healthcare, Universal Health Services, and Tenet Healthcare, which frequently utilize equity awards to incentivize executives.
• The specific number of options (14,000) and the exercise price ($157.13) would typically be benchmarked against similar roles and company size within the healthcare services sector to ensure competitive and fair compensation.
• The exemption under Rule 16b-3(d) for the grant and exercise of these options is standard for employee benefit plan transactions, reflecting common regulatory compliance in executive compensation.

Stakeholder Impact

• Shareholders: The grant of options aims to align executive incentives with shareholder value creation over the long term. Potential dilution upon exercise is a consideration.
• Employees: No direct impact on general employees is indicated.

Next Steps

• The stock options will vest in three annual installments, with the first vesting on February 23, 2027.
• The options will remain exercisable until their expiration date of February 24, 2031.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of stock options to a senior executive as part of their compensation package. While it aligns management incentives with long-term shareholder value, it does not provide new material information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

National Healthcare Corp, NHC, Stock Options, Executive Compensation, Form 4, Insider Transaction, Equity Incentive Plan, Timothy J. Shelly